Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches
Virginia Martin, Estéfani García‐Ríos, Michael J. McConnell, et al.
Trends in Microbiology (2020) Vol. 28, Iss. 11, pp. 900-912
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Long-Term Survival after Kidney Transplantation
Sundaram Hariharan, Ajay K. Israni, Gabriel M. Danovitch
New England Journal of Medicine (2021) Vol. 385, Iss. 8, pp. 729-743
Closed Access | Times Cited: 179
Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice
Sara Scarpini, Francesca Morigi, Ludovica Betti, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 551-551
Open Access | Times Cited: 63
Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection
Eleanor C. Semmes, Itzayana G. Miller, Courtney E. Wimberly, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 16
Open Access | Times Cited: 49
ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission
Eleanor C. Semmes, Itzayana G. Miller, Nicole Rodgers, et al.
JCI Insight (2023) Vol. 8, Iss. 13
Open Access | Times Cited: 23
The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
Camille N. Kotton, Deepali Kumar, Isabel Oriol, et al.
Transplantation (2025)
Closed Access | Times Cited: 1
Characterization of humoral and cellular immunologic responses to an mRNA-based human cytomegalovirus vaccine from a phase 1 trial of healthy adults
Kai Wu, Yixuan J. Hou, Dan Makrinos, et al.
Journal of Virology (2024) Vol. 98, Iss. 4
Open Access | Times Cited: 8
Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development
Xintao Hu, Hsuan-Yuan Wang, Claire E. Otero, et al.
Annual Review of Virology (2022) Vol. 9, Iss. 1, pp. 491-520
Open Access | Times Cited: 22
Relationship of maternal cytomegalovirus-specific antibody responses and viral load to vertical transmission risk following primary maternal infection in a rhesus macaque model
Claire E. Otero, Richard Barfield, Elizabeth A. Scheef, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 10, pp. e1011378-e1011378
Open Access | Times Cited: 11
Cell therapies for viral diseases: a new frontier
David Nardo, Emileigh G. Maddox, James L. Riley
Seminars in Immunopathology (2025) Vol. 47, Iss. 1
Open Access
Two Recombinant Cytomegalovirus Antigens Formulated with the SPA14 Adjuvant System: Impact of Temperature, pH and Excipients on the Stability of each Antigen and Adjuvant Component
John M. Hickey, Ozan S. Kumru, François Dalençon, et al.
Journal of Pharmaceutical Sciences (2025)
Open Access
Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
Nina Reuter, Barbara Kropff, William J. Britt, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 284-284
Open Access | Times Cited: 17
Novel monoclonal antibody-based therapies: implications for the treatment and prevention of HCMV disease
Marcos Nuévalos, Estéfani García‐Ríos, Francisco J. Mancebo, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 5, pp. 480-497
Closed Access | Times Cited: 10
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer
Matthias Zehner, Mira Alt, Artem Ashurov, et al.
Immunity (2023) Vol. 56, Iss. 11, pp. 2602-2620.e10
Open Access | Times Cited: 9
Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus
Hang Su, Xiaohua Ye, Daniel C. Freed, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 3
Open Access | Times Cited: 17
Characterization of Plasma Immunoglobulin G Responses in Elite Neutralizers of Human Cytomegalovirus
Melissa J. Harnois, Maria Dennis, Dagmar Stöhr, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 9, pp. 1667-1677
Open Access | Times Cited: 8
ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection
Eleanor C. Semmes, Itzayana G. Miller, Nicole Rodgers, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Cytomegalovirus Cell-mediated Immunity Assays in Pediatric Transplantation
W Otto, Surabhi B Vora, Daniel E. Dulek
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. Supplement_1, pp. S22-S30
Open Access | Times Cited: 1
Engineered HCMV‐infected APCs enable the identification of new immunodominant HLA‐restricted epitopes of anti‐HCMV T‐cell immunity
Maria Michela Santamorena, Sabine Tischer‐Zimmermann, Agnes Bonifacius, et al.
HLA (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 1
Circulatory follicular helper T lymphocytes associate with lower incidence of CMV infection in kidney transplant recipients
Patricia Suàrez-Fernández, Alberto Utrero‐Rico, Virginia Martin, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3946-3957
Open Access | Times Cited: 9
A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus
Marco Thomas, Barbara Kropff, Andreá Schneider, et al.
Journal of Virology (2021) Vol. 95, Iss. 18
Open Access | Times Cited: 8
Re-Emerging COVID-19: Controversy of Its Zoonotic Origin, Risks of Severity of Reinfection and Management
Bayissa Chala, Tigist Tilaye, Gemechis Waktole
International Journal of General Medicine (2023) Vol. Volume 16, pp. 4307-4319
Open Access | Times Cited: 3
Neutralizing antibodies with neurotropic factor treatment maintain neurodevelopmental gene expression upon exposure to human cytomegalovirus
Benjamin S. O’Brien, Rebekah L. Mokry, Megan L. Schumacher, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 3
Deciphering the Potential Coding of Human Cytomegalovirus: New Predicted Transmembrane Proteome
Francisco J. Mancebo, Marcos Parras-Moltó, Estéfani García‐Ríos, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2768-2768
Open Access | Times Cited: 5
Cross Strain Protection against Cytomegalovirus Reduces DISC Vaccine Efficacy against CMV in the Guinea Pig Model
K. Yeon Choi, Nadia S. El‐Hamdi, Alistair McGregor
Viruses (2022) Vol. 14, Iss. 4, pp. 760-760
Open Access | Times Cited: 5
Identification and Characterization of Epithelial Cell-Derived Dense Bodies Produced upon Cytomegalovirus Infection
Estéfani García‐Ríos, Maria Josefa Rodríguez, María C. Terrón, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1308-1308
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top